Unilever said in a press release Jan. 16 that it is still fighting to pursue GSK Consumer Healthcare as it looks to expand its presence in beauty, hygiene and health.
Unilever has been rejected three times.
“GSK Consumer Healthcare would be a strong strategic fit,” Unilever said in the press release, stating that the deal “would also deliver value and certainty for the shareholders of GSK and Pfizer.”
On Jan. 15, GSK released its own statement regarding Unilever’s bids, saying that the bids were unsolicited and undervalued the consumer healthcare business.
Unilever’s most recent bid to GSK was $68 billion, according to The New York Times.
